<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:department>Research and Enterprise Office</gtr:department><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EA6140A4-02E6-4F2F-BEA0-B0AEA445F086"><gtr:id>EA6140A4-02E6-4F2F-BEA0-B0AEA445F086</gtr:id><gtr:name>Smith and Nephew UK Limited</gtr:name><gtr:address><gtr:line1>York Science Park</gtr:line1><gtr:line2>Heslington</gtr:line2><gtr:postCode>YO10 5DF</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/21701621-358A-4514-AD54-E5C69F2C8CDF"><gtr:id>21701621-358A-4514-AD54-E5C69F2C8CDF</gtr:id><gtr:firstName>Margaret</gtr:firstName><gtr:otherNames>Caroline</gtr:otherNames><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4ED42CDD-EC45-4369-A11B-A75356E529D7"><gtr:id>4ED42CDD-EC45-4369-A11B-A75356E529D7</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:surname>Krauss</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/35BD288D-BD92-4F2F-A782-9EF6DEA273EB"><gtr:id>35BD288D-BD92-4F2F-A782-9EF6DEA273EB</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Wilkinson</gtr:surname><gtr:orcidId>0000-0003-4577-9479</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D7595489-4DB9-4C6F-A1D8-3AD9D4CBE4E7"><gtr:id>D7595489-4DB9-4C6F-A1D8-3AD9D4CBE4E7</gtr:id><gtr:firstName>Susan</gtr:firstName><gtr:surname>Stepney</gtr:surname><gtr:orcidId>0000-0003-3146-5401</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2555890A-15CD-4DEA-9E17-B61F742953CA"><gtr:id>2555890A-15CD-4DEA-9E17-B61F742953CA</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Johnson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/432091B6-4073-4E5C-AF15-361D72DCCB85"><gtr:id>432091B6-4073-4E5C-AF15-361D72DCCB85</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:otherNames>Alan</gtr:otherNames><gtr:surname>Bees</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FM027538%2F1"><gtr:id>244C85CC-37DD-4176-A98D-6109E048DCEB</gtr:id><gtr:title>TARGeTED: Tackling Antimicrobial Resistance through Goal-orientated Thinking in the EPS Disciplines</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/M027538/1</gtr:grantReference><gtr:abstractText>Antimicrobial resistance (AMR) is a serious threat to human and animal health. The problem is multifactorial, spans across many disciplines and involves stakeholders from right across society's spectrum. Our belief is that by engaging researchers from different disciplines, we can ask new questions and develop new solutions to the AMR challenge. Scientists engaged in EPS can bring novel insights and innovative technologies to many aspects of the AMR challenge but there are barriers to their engagement with goal-orientated, inter-disciplinary research. We have identified the conditions that lead to successful inter-disciplinary research outcomes; receptiveness, understanding, communication, resources and networks. We have put together a programme of activities that will create the time and space for researchers from EPS to engage in thinking about the AMR challenge in such a way that they will be able to identify tractable problems that they can solve. To start with we will focus on areas of research excellence currently being conducted at the University of York that have not to date been applied to AMR research, but promise to provide new insights and innovative solutions. These areas are 'Novel tools for understanding and controlling bacterial behaviour' and 'Novel biosensors and diagnostics'. We recognize that a successful 'Bridging the Gap' programme will bring together collaborations between researchers not yet engaged with the AMR agenda and we have incorporated into our activities strategies to reach these people. The outcome will be an exciting community of inter-disciplinary researchers working on the challenges of AMR that are communicating, sparking ideas, writing papers and applying for further funding.</gtr:abstractText><gtr:potentialImpactText>Three broad categories of beneficiary have been identified on three different timescales: Immediate, Intermediate and Long-term. 
 
Immediate beneficiaries (within 1-2 years) will be academics, and the research and support staff at UoY. The programme of activities we aim to support will help develop a culture of interdisciplinary 'goal-orientated' research, and lower barriers to collaboration. 
- Academics will benefit from new opportunities to win external funding, gain new collaborators, enjoy new research challenges and gain new skills. 
- Researchers engaging in pump priming projects will gain experience of working on tractable problems and will benefit from multiple interactions within an interdisciplinary environment. 
- Support staff will be trained in facilitation and programme delivery to enable them to support programme objectives more effectively. 
 
Intermediate beneficiaries (between 1 and 5 years) will be stakeholders such as industry, external academics, NHS collaborators and the general public. 
- Industry, academic and NHS partners will gain from new methods, ideas and opportunities for developing and refining approaches to their AMR-centred research with UoY staff. 
- The general public will benefit from an improved understanding of AMR, the challenges it imposes on individuals and society, and the complex and interdisciplinary nature of the solutions. 
 
Long-term beneficiaries (from 3-15 years onwards) are ultimately those suffering from the effects of AMR, but benefitting from improved treatments, faster diagnostic methods and decision-making tools, thus enhancing their quality of life. 
- Industry will gain economic benefit from application of new research and technologies into their products. 
- Professionals in the healthcare services will benefit from new practices, procedures and/or tools. 
- Policy makers, informed by the outcomes of the research, will review the impact of novel tools, knowledge and processes on health and welfare issues spanning health, economics, and societal agendas.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2015-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>402901</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>'Viral Interventions' is a diptych, derived using the antibiotic producing bacterium Streptomyces coelicolor, genetically modified in antibiotic production, with bacteriophages (sterilised), embroidery, silk.</gtr:description><gtr:id>DDE21138-3EFF-42FF-B77B-1DEF2FA87526</gtr:id><gtr:impact>The diptych, Viral interventions, was displayed at York art gallery from Dec 2016 to Jan, 2017. Plans for further exhibitions are also set for 2017 onwards.</gtr:impact><gtr:title>Anna Dumitriu</gtr:title><gtr:type>Artwork</gtr:type><gtr:url>http://www.normalflora.co.uk</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Unilever</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Partnership with Unilever Plc in relation to 'The biophysics of novel anti-biofilm treatments'</gtr:description><gtr:id>30917338-11DB-442D-BB4D-584F62C0AAEE</gtr:id><gtr:impact>This collaboration led directly to a successful application to Innovate UK, led by Unilever Plc, which has a total value to the University of York of &amp;pound;78,000</gtr:impact><gtr:partnerContribution>Worked collaboratively with our research team on the above mentioned work, and also enabled the York team to broaden their network of contacts in other reserach institutions to position us well for forthcoming biofilm-related funding calls.</gtr:partnerContribution><gtr:piContribution>Our work helped to demonstrate the feasibility of lactam analogues as components of cleaning products, by providing experimental evidence for efficacy and a mechanistic understanding of the process through visualisation and modelling. The work will achieve impact through guiding the development of anti-biofilm products that make up a component of Unilever's household care product line.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation at Physics in Food Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>38A3D575-DC2D-4D78-8F28-3B7967956DB1</gtr:id><gtr:impact>The talk analysed: Guided Mode Resonance Imaging- Monitoring Early Stage Biofilm Formation
Presented by: Yue (Christina) Wang, GT Triggs, Chris Reardon and Thomas F Krauss</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pint of Science</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D12C1232-E92C-4FE9-AA72-DB887C62B9EC</gtr:id><gtr:impact>an evening talking about the micro biome and antibiotics. The evening increased the debate on antibiotic resistance</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://pintofscience.co.uk/event/resistance-and-virulence/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plasma Conference (Bratislava, Slovakia)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2B744859-0F89-4284-B167-D416755F7A98</gtr:id><gtr:impact>International conference on plasma medicine: Dr Deborah O'Connell was invited to give a talk at this international conference on the COST microplasma reference source, which was used by members of our research team in work correlating the distribution of key reactive plasma generated species.
This served to disseminate our research to a wider academic audience and generated both questions and contacts within the field.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Delivery the Leeds Darwin Day lecture to the British Humanist Association</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AD2361A7-C0F5-4066-BA43-99AD91FB75F6</gtr:id><gtr:impact>British Humanist society invited me to deliver a lecture entitled 'Back to the Dark Ages; Evolution and antibiotic resistance'. This was a 1 hour lecture followed by 30 minutes of Q&amp;amp;A.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://humanism.org.uk/2017/02/09/is-humanity-heading-back-to-the-dark-ages-professor-maggie-smith-gives-the-first-ever-leeds-darwin-day-lecture/</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>sky news</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B91B5E32-8192-4686-B3F1-36E7960A3102</gtr:id><gtr:impact>Sky news filmed the research lab and interviews on the subject of AMR</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.gettyimages.co.uk/detail/video/shows-interior-shots-research-scientists-working-in-a-lab-news-footage/498266586</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Yornight</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F759CD7D-5E67-4382-9081-A3DB4B2C169B</gtr:id><gtr:impact>And evening of talks on the value of antibiotics, the micro biome and antibiotic resistance. Sparked discussion</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://yornight.com/2015/activities/medical-society/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TARGeTED 1st workshop</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8AF01FB0-8000-41E6-97B4-B5616A6B20D4</gtr:id><gtr:impact>We published a video of our first workshop that aimed to bring together researchers interested in AMR from different disciplines.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.york.ac.uk/staff/research/research-development/targeted-amr-project/launch-event/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2400</gtr:amountPounds><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Stage Abroad Fellowship</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>FAPESP</gtr:fundingOrg><gtr:id>6214D512-6E54-4440-91FD-692D3E10C86C</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The management and use of biofilms, Innovate UK/BBSRC</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>45C2CE4D-26BD-47ED-ADB0-F249796BDC26</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust CIDACTS studentships</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>0F9A382C-DBD5-44F2-A197-8EFF495FD685</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Healthcare Impact Partnerships</gtr:description><gtr:end>2020-05-02</gtr:end><gtr:fundingOrg>EPSRC and CRUK</gtr:fundingOrg><gtr:id>B9E130EC-F9AB-4C9F-BA7B-1F63D6A83070</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2017-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Feasibility studies to encourage better management and use of biofilms</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Unilever</gtr:fundingOrg><gtr:id>2886FDA5-B315-4746-8753-AD286CD2DAFE</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Innovate UK</gtr:department><gtr:description>Feasibility studies to encourage better management and use of biofilms.</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Government of the UK</gtr:fundingOrg><gtr:id>DA66DD92-4B78-4EE8-8AA6-CD55A04E6341</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>61000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Strategic Award</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>EPSRC and CRUK</gtr:fundingOrg><gtr:id>455EFB4A-AC3D-4163-B1A4-25965DFEF31B</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>James Burgess scholarship</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Burgess Road Surgery</gtr:fundingOrg><gtr:id>12487446-E779-45C1-AA6E-3FD12D7EA2E6</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>One project has already stimulated a collaboration with Unilever (see further funding)and this is ongoing. This project has also brought our researchers into contact with other biofilm researchers nationally.
New clinical relationships have been formed with colleagues at York Teaching Hospital. Industrial relationships have been formed with Unilever, Trajan Medical, Redx Pharma and Discover and continue with Smith and Nephew. 
The project has been very successful at stimulating interest in AMR from the general public and there have been many requests by public groups for talks and discussions. 
The project has also encouraged us to roll out 'antibiotics unearthed' in collaboration with local schools and the Microbiology Society. the students come to the department and attempt to identify soil bacteria that are making an antimicrobial. Similar projects are being rolled out to our undergraduate students.</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>66FB0F30-A13B-434A-8558-D13510F3001B</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:sector>Manufacturing, including Industrial Biotechology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Workshops, pump priming projects and other activities have stimulated a broad interest in AMR across the University. There is now a strong and coherent community of York PIs who are engaged in AMR research and either have or are planning to apply for research grants in the AMR field. York PIs in the physical sciences have already gained significant funding resulting from the pump priming. There has also been a good level of skills training at all research levels. Importantly there is a much greater level of interaction in this and other research areas between physical scientists and other disciplines, particularly biology.</gtr:description><gtr:exploitationPathways>Various, areas that align with pump priming projects (see other outputs)</gtr:exploitationPathways><gtr:id>C9BD8CFE-9A18-49FC-8D92-3AA04668C548</gtr:id><gtr:sectors><gtr:sector>Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>https://www.york.ac.uk/staff/research/research-development/targeted-amr-project/#tab-1</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6A8C4070-1C34-4EFB-8D46-FE7CBDE4AFDA"><gtr:id>6A8C4070-1C34-4EFB-8D46-FE7CBDE4AFDA</gtr:id><gtr:title>Spatial Dependence of DNA Damage in Bacteria due to Low-Temperature Plasma Application as Assessed at the Single Cell Level.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/72f3d78244e311af410996e794b70f85"><gtr:id>72f3d78244e311af410996e794b70f85</gtr:id><gtr:otherNames>Privat-Maldonado A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/M027538/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>